Stay updated on Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.

Latest updates to the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.3.2 instead of v3.3.1. There are no changes to study content, eligibility criteria, results, or site functionality.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision history shows an addition of Revision: v3.3.1 and removal of Revision: v3.2.0, a minor meta-update; no study content is affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check29 days agoChange DetectedRemoval of the site-wide government funding/operating-status notice. The core trial information, eligibility criteria, and study results remain unchanged.SummaryDifference0.4%

- Check43 days agoChange DetectedThe new screenshot shows only minor visual/layout adjustments with no changes to core study details such as eligibility criteria, interventions, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange Detected- The page now includes a notice about potential government funding lapse and current operating status, plus a link to the NIH Clinical Center and opm.gov for updates. - The version is updated from v3.1.0 to v3.2.0.SummaryDifference4%

- Check79 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Chemotherapy/Proton Reirradiation Clinical Trial page.